Overview
Joshua Zeidner is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Zeidner is rated as an Elite provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Zeidner is currently accepting new patients.
His clinical research consists of co-authoring 73 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles and participated in 3 clinical trials in the study of Myelodysplastic Syndrome (MDS).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Duke Blood Cancer Center
I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is rated as an Elite provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
University Of North Carolina At Chapel Hill
William Wood is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Wood is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wood is currently accepting new patients.
University Of North Carolina At Chapel Hill
James Coghill is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Coghill is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Coghill is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)Dr. Zeidner isElite. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaDr. Zeidner isElite. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)
- Distinguished
- Acute Myeloblastic Leukemia with MaturationDr. Zeidner isDistinguished. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myelomonocytic LeukemiaDr. Zeidner isDistinguished. Learn about Acute Myelomonocytic Leukemia.
- Childhood Acute Myeloid LeukemiaDr. Zeidner isDistinguished. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Zeidner isDistinguished. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Advanced
- Bone Marrow AspirationDr. Zeidner isAdvanced. Learn about Bone Marrow Aspiration.
- Chronic Myelogenous Leukemia (CML)Dr. Zeidner isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Multiple MyelomaDr. Zeidner isAdvanced. Learn about Multiple Myeloma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Zeidner isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Zeidner isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Promyelocytic LeukemiaDr. Zeidner isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Zeidner isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Zeidner isExperienced. Learn about Anemia.
- Aplastic AnemiaDr. Zeidner isExperienced. Learn about Aplastic Anemia.